Qube Research & Technologies Ltd

Position in TRDA — Entrada Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in TRDA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$448,017

-$655,639 QoQ

Shares Held

60,872

-30.4% QoQ

Ownership

0.156%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#43

of 128 holders

Holding Since

Dec 2022

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,068,185 across 169 Biotechnology names. TRDA ranks #129 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$448,017	60,872	-30.4%	Shares	Sole	2026-08-14
2026-03-31	$1,103,656	87,453	-50.3%	Shares	Sole	2026-05-15
2025-12-31	$1,809,465	176,018	-38.9%	Shares	Sole	2026-02-17
2025-09-30	$1,669,663	287,873	+115.3%	Shares	Sole	2025-11-14
2025-06-30	$898,665	133,730	+435.1%	Shares	Sole	2025-08-14
2025-03-31	$225,936	24,993	-35.6%	Shares	Sole	2025-05-15
2023-03-31	$562,339	38,782	+131.1%	Shares	Sole	2023-05-15
2022-12-31	$226,892	16,782	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.